He Lingyan, Sun Ling, Pan Haihua, Zhai Changlin
Jiaxing University Master Degree Cultivation Base, Zhejiang Chinese Medical University, 310053 Hangzhou, Zhejiang, China.
Department of Cardiology, The First Hospital of Jiaxing Affiliated Hospital of Jiaxing University, 314001 Jiaxing, Zhejiang, China.
Rev Cardiovasc Med. 2025 May 20;26(5):37359. doi: 10.31083/RCM37359. eCollection 2025 May.
Hypertension is a major risk factor for cardiovascular diseases (CVDs) and is closely related to metabolic abnormalities. The cardiometabolic index (CMI) integrates lipid profiles and anthropometric indicators, reflecting overall cardiometabolic health. However, the CMI and blood pressure (BP) relationship is poorly understood. Therefore, this study aimed to investigate the correlation between CMI and clinical BP and evaluate the potential of using this correlation as a cardiovascular risk indicator.
National Health and Nutrition Examination Survey (NHANES) data from 2015 to 2018 were used to calculate the CMI based on the triglycerides to high-density lipoprotein cholesterol ratio and the waist-to-height ratio. The relationship between CMI and systolic blood pressure (SBP)/diastolic blood pressure (DBP) was analyzed using multivariate regression, threshold effect analysis, and subgroup analysis.
In this study cohort of 4240 participants, CMI positively correlated with SBP and DBP. After adjusting for age, gender, and race, the partial correlation for SBP was 0.56 (95% CI: 0.19-0.93; < 0.01), while for DBP, it was 1.15 (95% CI: 0.60-1.71; < 0.001). The threshold effect analysis revealed a positive association with SBP when the CMI was below 6.83 (β = 1.44, 95% CI: 0.64-2.24; < 0.001) and a negative association when the CMI was above 6.83 (β = -1.52, 95% CI: -2.77- -0.28; = 0.0123). For the DBP, a positive correlation was found when the CMI was below 2.81 (β = 1.45, 95% CI: 0.10-2.79; = 0.0345), and a negative correlation when the CMI was above 2.81 (β = -1.92, 95% CI: -3.08- -0.77; = 0.0012). A strong interaction was observed between the CMI and gender for the SBP ( = 0.0054) and a trend for the interaction between CMI and age for the DBP ( = 0.1667).
This study found a significant positive correlation between the CMI and BP, with threshold effects supporting a non-linear relationship. The strong interaction between the CMI and gender for SBP suggests that the influence of the CMI on BP may be gender-dependent. These results highlight the importance of utilizing CMI in personalized cardiovascular risk stratification and underscore the relevance of considering patient factors such as gender in managing hypertension.
高血压是心血管疾病(CVDs)的主要危险因素,与代谢异常密切相关。心脏代谢指数(CMI)整合了血脂谱和人体测量指标,反映整体心脏代谢健康状况。然而,CMI与血压(BP)之间的关系尚不清楚。因此,本研究旨在探讨CMI与临床血压之间的相关性,并评估利用这种相关性作为心血管风险指标的潜力。
使用2015年至2018年美国国家健康与营养检查调查(NHANES)的数据,根据甘油三酯与高密度脂蛋白胆固醇的比值以及腰高比来计算CMI。采用多元回归、阈值效应分析和亚组分析来分析CMI与收缩压(SBP)/舒张压(DBP)之间的关系。
在本研究的4240名参与者队列中,CMI与SBP和DBP呈正相关。在调整年龄、性别和种族后,SBP的偏相关系数为0.56(95%CI:0.19 - 0.93;P < 0.01),而DBP的偏相关系数为1.15(95%CI:0.60 - 1.71;P < 0.001)。阈值效应分析显示,当CMI低于6.83时与SBP呈正相关(β = 1.44,95%CI:0.64 - 2.24;P < 0.001),当CMI高于6.83时呈负相关(β = -1.52,95%CI:-2.77 - -0.28;P = 0.0123)。对于DBP,当CMI低于2.81时呈正相关(β = 1.45,95%CI:0.10 - 2.79;P = 0.0345),当CMI高于2.81时呈负相关(β = -1.92,95%CI:-3.08 - -0.77;P = 0.0012)。观察到CMI与性别在SBP方面存在强交互作用(P = 0.0054),CMI与年龄在DBP方面存在交互作用趋势(P = 0.1667)。
本研究发现CMI与血压之间存在显著正相关,阈值效应支持非线性关系。CMI与性别在SBP方面的强交互作用表明CMI对血压的影响可能存在性别依赖性。这些结果突出了在个性化心血管风险分层中利用CMI的重要性,并强调在管理高血压时考虑性别等患者因素的相关性。